Edinburgh Biosciences Ltd. (EBS) is pleased to announce it has received a SMART: SCOTLAND grant for just under £100K to develop an Epi-fluorescence surface scanner (EFSCAN) for in situ detection of protein contamination. This grant will allow EBS to extend the pioneering collaboration with University of Edinburgh aimed at developing an instrument to allow routine screening for contamination on surgical instruments. There is growing awareness of and concern at previously unknown and undetectable levels of contamination on surgical instruments even after sterilisation. Detailed analyses undertaken using a prototype EFSCAN system show highly promising results. The SMART: SCOTLAND grant will allow further development of the system with the intention of achieving commercial readiness by the completion of the grant period.
EBS will continue its collaboration with University of Edinburgh to this end and will widen its scope of activities to include chosen hospitals in Scotland and elsewhere in UK for field trials.
EBS will also explore other markets in which biological contamination of materials is of concern.